Abstract
The synthesis and biological activity of novel glycoprotein IIb–IIIa antagonists containing the 3,9-diazaspiro[5.5]undecane nucleus are described. The potent activity of these compounds as platelet aggregation inhibitors demonstrates the utility of the spirocyclic structures as a central template for nonpeptide RGD mimics.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have